Endometriosis Treatment Market Forecast to Grow to USD 3.37 billion by 2031 with Increased Demand for Hormonal and Pain-Management Therapies

Mordor Intelligence has published a new report on endometriosis treatment market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction:

The endometriosis treatment market is gaining traction as a critical healthcare segment dedicated to addressing a painful chronic condition affecting women of reproductive age globally. According to recent industry research, The Endometriosis Treatment Market market is expected to grow from USD 1.77 billion in 2025 to USD 1.97 billion in 2026 and is forecast to reach USD 3.37 billion by 2031 at 11.34% CAGR over 2026-2031, reflecting a steady rise in demand for targeted therapies and improved patient access to care during the forecast period. This growth is supported by increased awareness campaigns, regulatory approvals for novel therapeutic agents, and expanding healthcare infrastructure in emerging regions.

Endometriosis, characterized by the growth of endometrial-like tissue outside the uterus, leads to significant pain, infertility, and reduced quality of life. These factors are driving women and healthcare providers to seek more effective, long-term treatment options. The endometriosis treatment market analysis highlights how patient needs and treatment innovation are shaping the competitive landscape, with a focus on both symptomatic relief and disease management.

Report Overview:

https://www.mordorintelligence.com/industry-reports/endometriosis-treatment-market?utm_source=openpr

Key Trends in the Global Endometriosis Treatment Market

Rising Prevalence and Awareness Driving Market Expansion

One of the central trends in the endometriosis treatment market trends is the rising prevalence of endometriosis among women of reproductive age and broader efforts to raise awareness. More than 190 million women worldwide live with the condition, with prevalence estimates higher in some regions of Asia compared to Western populations. These dynamics are prompting enhanced screening efforts, earlier diagnosis, and greater emphasis on patient education, which collectively support treatment uptake and market growth.

Approval and Uptake of New Therapeutic Classes

Regulatory approvals for newer classes of drugs, particularly oral gonadotropin-releasing hormone (GnRH) antagonists, are influencing treatment patterns. These agents provide a balance of treatment efficacy and improved tolerability compared to older therapies, encouraging broader adoption by physicians and patients alike. Their convenience and effectiveness in pain management have made them a key factor in shaping market strategies.

Emergence of Digital Care Platforms

In response to delays in diagnosis and specialist shortages, digital health platforms and remote monitoring tools are gaining attention. These FemTech solutions help patients track symptoms, access teleconsultations, and connect with healthcare services, particularly in underserved regions. The ability to integrate remote care into treatment plans enhances patient engagement and supports consistent management of symptoms.

Shift in Treatment Focus to Broader Patient Needs

The market is seeing a shift toward diversified care options that balance hormonal interventions with pain management and non-hormonal approaches. While hormone therapies continue to dominate revenue, alternative formulations and treatment regimens that address patient preferences, fertility concerns, and side-effect profiles are becoming part of clinical practice.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:https://www.mordorintelligence.com/ja/industry-reports/endometriosis-treatment-market?utm_source=openpr

Market Segmentation in the Endometriosis Treatment Market

The endometriosis treatment market share spans a variety of segments that reflect patient needs and therapeutic preferences. The major segments include:

By Drug Class:

Gonadotropin-Releasing Hormone (GnRH) Therapies

Oral Contraceptives

NSAIDs

Emerging Non-Hormonal Agents

Within these categories, GnRH therapies continue to hold a significant share of total market revenue, supported by new oral antagonist approvals, while oral contraceptives and non-hormonal options are growing due to their suitability for fertility-conscious patients.

By Treatment Type:

Hormone Therapy

Pain-Management Drugs

Combination Approaches

By Route of Administration:

Oral Products

Injectables

Other Delivery Methods

By Distribution Channel:

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

By Geography

North America

South Amerca

Middle east&Africa

Europe

Asia pacific

Key Players in the Endometriosis Treatment Market

The endometriosis treatment market includes a range of pharmaceutical companies and healthcare providers pursuing strategic initiatives to strengthen their positions. Established global firms with diverse women's health portfolios are actively involved in the development and commercialization of therapies. These companies focus on expanding geographic presence, pursuing clinical studies, and offering products across multiple therapeutic classes to meet evolving patient needs.

Bayer AG

Pfizer Inc.

AbbVie Inc.

Teva Pharmaceutical Industries

AstraZeneca

Conclusion:

The endometriosis treatment market growth is anchored in sustained demand for better, more effective treatment modalities and heightened awareness of the condition's impact on women's health. As the market expands toward the projected forecast value by 2030, treatment developers and healthcare stakeholders are positioned to benefit from increased investment, favorable regulatory landscapes, and greater patient engagement in care pathways.

Ongoing efforts to reduce diagnostic delays, improve access to specialists, and integrate digital health tools into treatment strategies are expected to support broader reach and improved quality of care. Moreover, the diversification of treatment options, including both hormonal and non-hormonal approaches, is likely to strengthen overall treatment adoption and enhance patient outcomes.

For complete market analysis, please visit the Mordor Intelligence page:

https://www.mordorintelligence.com/industry-reports/endometriosis-treatment-market?utm_source=openpr

Industry related Reports:

Infertility Drugs Market : The Infertility Drugs Market Report is Segmented by Drug Class (Gonadotropins, Selective Estrogen Receptor Modulators (SERMs), and More), Patient Gender (Female and Male), Route of Administration (Oral, and More), Distribution Channel (Hospital Pharmacies, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America).

Get more Insights : https://www.mordorintelligence.com/industry-reports/infertility-drugs-market?utm_source=openpr

Gynecology Drugs Market : The Gynecology Drugs Market Report is Segmented by Therapeutic Class (Hormonal Therapy, Non-Hormonal Therapy), Indication (Contraception, Gynecology Infections and More), Route of Administration (Oral, Parenteral, and More), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and More), and Geography (North America, Europe, and More).

Get more Insights : https://www.mordorintelligence.com/industry-reports/gynecology-drugs-market?utm_source=openpr

Endometrial Cancer Market : The Endometrial Cancer Market Report is Segmented by Type of Cancer (Endometrial Carcinoma [Adenocarcinoma, Carcinosarcoma, and More], and Uterine Sarcomas), Type of Therapy (Immunotherapy, Radiation Therapy, and More), Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, and More), and Geography (North America, Europe, Asia-Pacific, and More).

Get more Insights : https://www.mordorintelligence.com/industry-reports/endometrial-cancer-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.